Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,560,030
  • Shares Outstanding, K 36,904
  • Annual Sales, $ 394,110 K
  • Annual Income, $ 25,680 K
  • 60-Month Beta 0.97
  • Price/Sales 6.99
  • Price/Cash Flow 51.48
  • Price/Book 9.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.29
  • Number of Estimates 5
  • High Estimate 0.30
  • Low Estimate 0.26
  • Prior Year 0.13
  • Growth Rate Est. (year over year) +123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.28 +0.13%
on 03/22/19
82.10 -15.51%
on 02/25/19
-12.10 (-14.85%)
since 02/22/19
3-Month
58.47 +18.63%
on 12/24/18
86.70 -19.99%
on 02/21/19
+9.08 (+15.06%)
since 12/21/18
52-Week
30.04 +130.93%
on 04/02/18
92.18 -24.75%
on 11/07/18
+37.57 (+118.14%)
since 03/22/18

Most Recent Stories

More News
Why Is Genomic Health (GHDX) Down 4.8% Since Last Earnings Report?

Genomic Health (GHDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GHDX : 69.37 (-7.05%)
Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up

Geron (GERN) posts loss in line with the estimate in fourth-quarter 2018 but beats on revenues. Operating expenses increase on a year-over-year basis.

CELG : 88.15 (-1.65%)
GHDX : 69.37 (-7.05%)
JNJ : 136.91 (-0.86%)
GERN : 1.69 (-7.65%)
After Yesterday's Decline of 1.99%, Genomic Health I Offers Investors Better Value

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $74.01 to a high of $76.76. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of...

GHDX : 69.37 (-7.05%)
Esperion (ESPR) Reports Wider-Than-Expected Loss in Q4

Esperion Therapeutics (ESPR) generates no revenues in the fourth quarter. The company provides guidance for 2019.

ESPR : 41.39 (-6.42%)
CELG : 88.15 (-1.65%)
GHDX : 69.37 (-7.05%)
MRK : 82.29 (-0.80%)
Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales

Spectrum Pharma (SPPI) misses bottom-line estimates in the fourth quarter but beats on revenues.

SPPI : 9.57 (-6.27%)
CELG : 88.15 (-1.65%)
GHDX : 69.37 (-7.05%)
AMGN : 186.70 (-2.70%)
Sarepta (SRPT) Q4 Earnings Lag Estimates, Exondys 51 Sales Up

Sarepta (SRPT) misses estimates for both earnings and sales in fourth-quarter 2018. However, Exondys 51 performs well on strong demand.

CELG : 88.15 (-1.65%)
GHDX : 69.37 (-7.05%)
SRPT : 122.26 (-3.47%)
BMRN : 88.05 (-3.01%)
Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues

Arena Pharmaceuticals (ARNA) outpaces earnings estimates in Q4. Also, the top line surpasses the consensus mark. Shares Up.

CELG : 88.15 (-1.65%)
GHDX : 69.37 (-7.05%)
ARNA : 43.23 (-5.32%)
UTHR : 120.80 (-1.78%)
Earnings Estimates Rising for Genomic Health (GHDX): Will It Gain?

Genomic Health (GHDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GHDX : 69.37 (-7.05%)
Genomic Health I Set to Possibly Rebound After Yesterday's Selloff of 5.79%

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $75.37 to a high of $86.60. Yesterday, the shares fell 5.8%, which took the trading range below the 3-day low of...

GHDX : 69.37 (-7.05%)
Diagnostic Solutions Laboratory Revolutionizes Precision Medicine with GenomicInsight(TM) Genomic Health Profile Powered by Opus23 Explorer(TM)

Diagnostic Solutions Laboratory (DSL) continues its innovative vision to transform and improve personalized medicine by introducing its first DNA SNP test, GenomicInsight(TM) Genomic Health Profile powered...

GHDX : 69.37 (-7.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade GHDX with:

Business Summary

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict...

See More

Key Turning Points

2nd Resistance Point 76.14
1st Resistance Point 72.75
Last Price 69.37
1st Support Level 67.63
2nd Support Level 65.90

See More

52-Week High 92.18
Last Price 69.37
Fibonacci 61.8% 68.44
Fibonacci 50% 61.11
Fibonacci 38.2% 53.78
52-Week Low 30.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar